Skip to main content
logo
TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.990
-0.020 (-0.50%)
Mar 26, 2026, 9:54 AM EDT - Market open

TriSalus Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
24534915722382309
Market Cap Growth
72.14%122.70%-29.79%171.26%-73.35%-
Enterprise Value
252.48363.2172.1212.66238.47309.09
Last Close Price
3.996.985.018.4510.039.88
PE Ratio
--3.79-3.82-1.25-0.06-0.08
PS Ratio
5.287.735.3212.066.64-
PB Ratio
--10.31-6.05-8.25-0.47-18.47
P/TBV Ratio
-4.47-7.81-4.90-2.93-0.02-0.13
P/FCF Ratio
--18.44-3.80-4.36-2.50-177.64
P/OCF Ratio
--19.38-3.84-4.41-2.55-177.64
EV/Sales Ratio
5.598.045.8511.4919.23-
EV/EBITDA Ratio
--13.80-4.86-3.95-6.62-101.65
EV/EBIT Ratio
--13.48-4.76-3.90-6.54-101.65
EV/FCF Ratio
--19.19-4.18-4.16-7.23-177.83
Debt / Equity Ratio
-1.02-1.02-0.92-0.05-0.010.00
Debt / EBITDA Ratio
-1.32-1.32-0.68-0.03-0.05-0.18
Debt / FCF Ratio
-1.84-1.84-0.59-0.03-0.06-0.31
Net Debt / Equity Ratio
-0.42-0.42-0.600.380.0414.94
Net Debt / EBITDA Ratio
-0.55-0.55-0.440.190.2182.11
Net Debt / FCF Ratio
-0.76-0.76-0.380.200.23143.64
Asset Turnover
1.521.521.210.790.090
Inventory Turnover
1.961.961.241.303.07-
Quick Ratio
2.352.351.331.040.34156.22
Current Ratio
2.802.802.021.420.530.33
Return on Equity (ROE)
131.25%131.25%113.42%58.35%-165.64%2.06%
Return on Assets (ROA)
-90.86%-90.86%-148.89%-233.80%-26.74%-1.21%
Return on Invested Capital (ROIC)
-560.63%-560.63%-1541.58%-83155.33%-13895.18%3739.38%
Return on Capital Employed (ROCE)
-143.43%-143.43%-305.78%24157.43%-30.55%-1.21%
Earnings Yield
-29.22%-26.36%-26.15%-80.12%-1610.67%-1332.49%
FCF Yield
-7.94%-5.42%-26.28%-22.92%-40.07%-0.56%
Buyback Yield / Dilution
-6.57%-6.57%-9.96%-16.58%-0.11%0.00%
Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q